Blog Posts

Honoring Steve Mathews’ 27-Year-Long Remarkable Journey – NFCR

NFCR/LinkedIn

Jul 17, 2025, 10:03

Honoring Steve Mathews’ 27-Year-Long Remarkable Journey – NFCR

National Foundation for Cancer Research (NFCR) shared a post on LinkedIn:

“Glioblastoma Awareness Day — a day to shed light on one of the most aggressive and deadly forms of brain cancer.

We’re honoring the legacy of Steve Mathews, who defied the odds after a GBM diagnosis and became a source of strength and hope for countless families.

Steve was given just two years to live… but lived 27 more—thanks to a clinical trial and an unshakable will to keep going.

On this day of awareness, let’s remember why research matters and why every moment gained is a victory.

Read Steve’s powerful story.”

Honoring Steve Mathews’ 27-Year-Long Remarkable Journey - NFCR

You can also read:

Glioblastoma Awareness Day 2025: Uniting for Progress and Hope

glioblastoma_OncoDaily

brain cancer cancer cancer awareness glioblastoma Glioblastoma Awareness Day National Foundation for Cancer Research NFCR OncoDaily Oncology Steve Mathews

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Author?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...